Is it a good company at a reasonable price? When dividends are cut, it is never a good sign. It seems to reflect a negative view of the future by the company. So, I believe caution on buying this stock is warranted.
I do not own this stock of Maple Leaf Foods Inc (TSX-MFI, OTC-MLFNF). I am doing a report on this stock because it was on the Top 100 Canadian Dividend Stocks by Maple Money . Note that this list does not seem to have changed since 2022. It also was on the Top 100 Dividend Stocks Money Sense for 2021 gets a solid C Rating from Money Sense. For the Money Sense list, this stock in 2025 gets an E rating
When I was updating my spreadsheet, I noticed this company has decreased their dividends by 21% for December 2025 Dividend Payment. The last time the dividends were decreased was in 1995. I have 34 years of dividend data. Dividend have been increased in 10 years and decreased in 2 years. See the press release from Maple Leaf Foods Inc on this.
If you had invested in this company in December 2014, for $1,012.44 you would have bought 52 shares at $19.47 per share. In December 2024, after 10 years you would have received $317.20 in dividends. The stock would be worth $939.64. Your total return would have been $1,256.84. This would be a total return of 2.42% per year with 0.74% from capital loss and 3.17% from dividends.
| Cost | Tot. Cost | Shares | Years | Dividends | Stock Val | Tot Ret |
|---|---|---|---|---|---|---|
| $19.47 | $1,012.44 | 52 | 10 | $317.20 | $939.64 | $1,256.84 |
The current dividend yield is moderate with a recent dividend cut. The current dividend is moderate (2% to 4% ranges) at 3.00%. The 5 and 10 year median dividend yields are moderate at 3.07% and 2.27%. The historical median dividend yield is low (below 2%) at 1.49%. Dividends have been increasing since 2015, but this year the company cut the dividends by 21%. This is the last dividend change and it is for the December 2025 dividend payment.
The Dividend Payout Ratios (DPR) need improving and analysts believe it will be. The DPR for 2024 for Earnings per Share (EPS) is far too high at 113% with 5 year coverage 5 year coverage non-calculable due to earning losses. The DPR for 2024 for Adjusted Earnings per Share (AEPS) is far too high at 113% with 5 year coverage at 236%. The DPR for 2024 for Cash Flow per Share (CFPS) is good at 28% with 5 year coverage too high at 64%. The DPR for 2024 for Free Cash Flow (FCF) is good at 25% with 5 year coverage at 31%. FCF for 2024 varies from $368.3M to $460M. I am using the $460M value.
| Item | Cur | 5 Years |
|---|---|---|
| EPS | 112.82% | 0.00% |
| AEPS | 112.82% | 235.64% |
| CFPS | 27.33% | 64.42% |
| FCF | 25.13% | 30.76% |
Debt Ratios are fine. The Long Term Debt/Market Cap Ratio for 2024 is fine at 0.62 and currently good at 0.47. The Liquidity Ratio for 2024 is low at 1.23 and 1.26 currently. If you added in Cash Flow after dividends, the ratios are fine at 1.54 and currently at 1.47. The Debt Ratio for 2024 is good at 1.53 and 1.51 currently. The Leverage and Debt/Equity Ratios for 2024 are fine at 2.88 and 1.88 and currently at 2.95 and 1.95.
| Type | Year End | Ratio Curr |
|---|---|---|
| Lg Term R | 0.62 | 0.47 |
| Intang/GW | 0.15 | 0.11 |
| Liquidity | 1.23 | 1.26 |
| Liq. + CF | 1.54 | 1.47 |
| Debt Ratio | 1.53 | 1.51 |
| Leverage | 2.88 | 2.95 |
| D/E Ratio | 1.88 | 1.95 |
The Total Return per year is shown below for years of 5 to 34 to the end of 2024. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.
| From | Years | Div. Gth | Tot Ret | Cap Gain | Div. |
|---|---|---|---|---|---|
| 2018 | 5 | 8.70% | -3.45% | -6.93% | 3.48% |
| 2013 | 10 | 18.59% | 2.42% | -0.74% | 3.17% |
| 2008 | 15 | 12.04% | 5.81% | 2.96% | 2.85% |
| 2003 | 20 | 8.90% | 3.07% | 0.95% | 2.12% |
| 1998 | 25 | 7.06% | 2.93% | 1.03% | 1.90% |
| 1993 | 30 | 2.84% | 3.14% | 1.30% | 1.84% |
| 1990 | 34 | 2.50% | 3.62% | 1.50% | 2.11% |
The 5-year low, median, and high median Price/Earnings per Share Ratios are 18.58, 26.79, 33.65. The corresponding 10 year ratios are 21.07, 27.42 and 34.33. The corresponding historical ratios are 16.76, 19.72 and 24.60. The current ratio is 23.64 based on Stock Price of $25.30, EPS estimate for 2025 of $1.07. The current ratio is between the low and median ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.
I also have Adjusted Earnings per Share (AEPS) data. The 5-year low, median, and high median Price/Adjusted Earnings per Share Ratios are 19.82, 26.79 and 30.74. The corresponding 10 year ratios are 20.76, 26.10 and 30.23. The corresponding historical ratios are 20.55, 25.09 and 29.41. The current ratio is 24.56 based on Stock Price of $25.30, AEPS estimate for 2025 of $1.03. The current ratio is between the low and median ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.
I get a Graham Price of $16.82. The 10-year low, median, and high median Price/Graham Price Ratios are 1.16, 1.44, 1.69. The current P/GP Ratio is 1.50 based on a stock price of $25.30. The current ratio is between the median and high ratios of the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable but above the median.
I get a 10-year median Price/Book Value per Share Ratio of 1.74. The current ratio is 2.07 based on Book Value of $1,510M, Book Value per Share of $12.20 and a stock price of $25.30. The current ratio is 19% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.
I also have Book Value per Share estimate for 2025 of $11.83. This implies a Book Value of $1,464M and a ratio of 2.14 based on a stock price of $25.30. This ratio is 23% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.
I get a 10-year median Price/Cash Flow per Share Ratio of 12.01. The current ratio is 8.66 based on Cash Flow per Share estimate for 2025 of $2.92, Cash Flow of $361.4M and a stock price of $25.30. The current ratio is 28% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.
I get an historical median dividend yield of 1.49%. The current dividend is 3% based on Dividends of $0.76 and a stock price of $25.30. The current dividend yield is 102% above the historical median dividend yield. This stock price testing suggests that the stock price is relatively cheap.
I get a 10 year median dividend yield of 2.27%. The current dividend is 3% based on Dividends of $0.76 and a stock price of $25.30. The current dividend yield is 32% above the historical median dividend yield. This stock price testing suggests that the stock price is relatively cheap.
The 10-year median Price/Sales (Revenue) Ratio is 0.82. The current is 0.80 based on Revenue estimate for 2025 of $3,927M. Revenue per Share of $31.73 and a stock price of $25.30. The current ratio is 3% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.
Results of stock price testing is that the stock price is probably reasonable. The dividend yield testing says that the stock price is relatively cheap. The P/S Ratio test does not confirm this but says the stock price is relatively reasonable and below the median. The rest of the testing goes from cheap to expensive.
When I look at analysts’ recommendations, I find Strong Buy (4), Buy (3), and Hold (2). The consensus is a Strong Buy. The 12 month stock price consensus is $33.88 with a high of $42.00 and low of $27.00. The consensus stock price of $33.88 implies a total return of 36.92% with 33.91% from capital gains and 3.00% from dividends based on a current stock price of $25.30.
Last year when I look at analysts’ recommendations, I found Strong Buy (3), and Buy (2). The consensus would be a Strong Buy. The 12 month stock price consensus is $29.80 with a high of $34.00 and low of 26.00. The 12 month consensus price implies a total return of 40.22% with 36.20% from capital gains and 4.02% from dividends based on a stock price of $21.88. What happened was an increase in stock price of $21.88 to $25.30, a 15.63% increase for a total return of 19.65% with 4.02% from dividends.
Analysts on Stock Chase mainly to say to watch the stock as it may improve. One says it is too volatile for a consumer staples company. I must say that I do agree with that assessment. Christopher Liew on Motley Fool says that Buy Canada movement help the company and made it into a stock for long term investors. Chris MacDonald on Motley Fool thinks this stock is a passive income gem. The company put out a Press Release about their year-end results for 2024. The company put out a Press Release about their third quarter of 2025 results.
Simply Wall Street via Yahoo Finance reviews this stock. They think it is undervalued. They also say that Maple Leaf Foods (TSX-MFI) just signed on as the Official Protein Partner of Team Canada for the 2026 and 2028 Olympics, a branding move that has quickly focused investor attention on the stock.
Maple Leaf Foods Inc is a protein company that responsibly produces food products under brands including Maple Leaf, Maple Leaf Prime, Maple Leaf Natural Selections, Schneiders, Mina, Greenfield Natural Meat Co., Lightlife and Field Roast. The Company's portfolio includes prepared meats, ready-to-cook and ready-to-serve meals, and valued-added fresh pork and poultry, and plant protein products. Its main markets are Canada, the United States, Japan, and China. Its web site is here Maple Leaf Foods Inc.
The last stock I wrote about was about was Element Fleet Management Corp (TSX-EFN, OTC-ELEEF) ... learn more. The next stock I will write about will be KP Tissue Inc (TSX-KPT, OTC-KPTSF) ... learn more on Wednesday, December 17, 2025 around 5 pm. Tomorrow on my other blog I will write about Canadian Banks Fourth Quarters.... learn more on Tuesday, December 16, 2025 around 5 pm.
This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.
See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.